high-titer RSV immune globulin RI-001
Term · Oncology and biomedicine · MLC-T-ONC-014127
A plasma-derived, polyclonal, intravenous immunoglobulin formulation (IVIG) containing standardized high levels of antibodies against respiratory syncytial virus (RSV), a single-stranded, enveloped paramyxovirus, with potential immunomodulating activity. The high-titer RSV immune globulin RI-001 is derived from healthy donors with high amounts of RSV antibodies. Upon intravenous administration, the antibodies against RSV may provide passive immunization against RSV. This may prevent lower respiratory tract infections by RSV in immunocompromised patients. The polyclonal antibodies in RI-001 are able to target various viral epitopes.
| Identifier | MLC-T-ONC-014127 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014127",
"term": "high-titer RSV immune globulin RI-001",
"field": "Oncology and biomedicine",
"definition": "A plasma-derived, polyclonal, intravenous immunoglobulin formulation (IVIG) containing standardized high levels of antibodies against respiratory syncytial virus (RSV), a single-stranded, enveloped paramyxovirus, with potential immunomodulating activity. The high-titer RSV immune globulin RI-001 is derived from healthy donors with high amounts of RSV antibodies. Upon intravenous administration, the antibodies against RSV may provide passive immunization against RSV. This may prevent lower respiratory tract infections by RSV in immunocompromised patients. The polyclonal antibodies in RI-001 are able to target various viral epitopes.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/high-titer-rsv-immune-globulin-ri-001/"
}
Record 8,515 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.